Archives
I recently did a podcast episode on heparin (which you can listen to below) and I did not mention hair loss as a potential adverse effect. In addition to heparin, it turns out there is data on other anticoagulants and this adverse effect as well. That begs the question, what should we do about this? […]
Read More
As a healthcare professional, when I hear the term heparin-induced thrombocytopenia (HIT), I get nervous. The classically taught heparin-induced thrombocytopenia (type 2) is very serious. HIT is something that needs to be closely watched for because consequences from it can include life-threatening thrombosis. Type 1 heparin-induced thrombocytopenia is considered less serious. Type 1 HIT involves […]
Read More
One of the big advantages of newer agents like rivaroxaban is there’s less potential for diet and drug interactions than with warfarin. Now that doesn’t mean that there aren’t any rivaroxaban drug interactions. We have to pay attention to these agents, and I’m going to give you some examples of meds that we really need […]
Read More
An 81 year old male was diagnosed with a right knee deep venous thrombosis (DVT) during a several week stay in the Dominican Republic. He was started on warfarin, dose and duration unknown, and instructed to present to the emergency department upon his return to the United States. It is unknown if he received parenteral […]
Read More
This is often a hot button issue with students. In the US, we work with medications that don’t always have the same name. What’s important, knowing brand name medication versus generic names? – Let me give you an answer you probably won’t like hearing 🙂 Take warfarin for example. The generic name is warfarin, but […]
Read More